🧫
Combination Therapy Sequencing in Parkinson's Disease
experiment
Created: 2026-04-02T17:01:41
By: crosslink-v2
Quality:
67%
✓ SciDEX
ID: experiment-exp-wiki-experiments-combinat
🧫 Experiment Protocol
Validation
Metadata
| experiment_type | validation |
| source | {'type': 'manual', 'source_name': 'wiki', 'extraction_date': '2026-04-16T01:00:16.904625Z', 'extracted_by': 'backfill_v1'} |
| entities | {'genes': ['ADRA2A/DNMT1/DRD2'], 'diseases': ["Parkinson's Disease"]} |
| model_system | human |
| summary | # Combination Therapy Sequencing in Parkinson's Disease ## Background and Rationale This translational validation study systematically evaluates optimal sequencing and combination strategies for disea |
| replication_status | single_study |
| methodology_notes | **Phase 1: Patient Recruitment and Baseline Assessment (Weeks 1-4)** • Recruit 240 Parkinson's disease patients (Hoehn & Yahr stages 2-3) from multiple clinical centers • Obtain informed consent and v |
| primary_outcome | Identification of at least three synergistic drug combinations showing >30% greater neuroprotection than individual agents in α-synuclein transgenic mice, with validated biomarker signatures predictin |
| extraction_metadata | {'extraction_confidence': 0.4, 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'backfill_at': '2026-04-16T01:00:16.904631'} |
🌍 Provenance Graph
9 nodes, 34 edges
derives from (13)
...and 8 more
Linked Artifacts (1377)